NASDAQ : AVDL
$0 (0.0%)
| Source | Headline |
|---|---|
|
Alkermes: 'Buy' On Avadel Acquisition And Positive NT2 Data With Alixorexton
Alkermes plc maintains a Buy rating, driven by the accretive Avadel Pharmaceuticals acquisition and strong pipeline progress. Company bolstered its hypersomnolence portfolio with LUMRYZ, which delivered robust early sales and revenue momentum post-acquisition. Positive phase 2 data for alixorexton in narcolepsy type 2 and ongoing phase 3 Brilliance Studies underpin a compelling growth thesis. seekingalpha.com - 2026-06-19 15:49:55 |
Sign up for InvestorConsensus.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Last Month
Last Quarter
Last Year
All Time
| Date | Analyst Firm | Action | Previous Grade | New Grade |
|---|---|---|---|---|
| 2025-11-20 | Wells Fargo | Maintain | Equal Weight | Equal Weight |
| 2025-11-07 | Wells Fargo | Maintain | Equal Weight | Equal Weight |
| 2025-10-28 | UBS | Downgrade | Buy | Neutral |
| 2025-10-23 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| 2025-10-23 | Leerink Partners | Downgrade | Outperform | Market Perform |
| 2025-10-22 | Jefferies | Downgrade | Buy | Hold |
| 2025-10-22 | Needham | Downgrade | Buy | Hold |
| 2025-09-05 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2025-08-21 | UBS | Maintain | Buy | Buy |
| 2025-08-08 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2025-05-08 | Needham | Maintain | Buy | Buy |
| 2025-04-09 | Needham | Maintain | Buy | Buy |
| 2025-03-04 | Needham | Maintain | Buy | Buy |
| 2025-03-04 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2025-03-03 | Needham | Maintain | Buy | Buy |
| 2025-01-13 | UBS | Maintain | Buy | Buy |
| 2025-01-10 | Piper Sandler | Maintain | Overweight | Overweight |
| 2025-01-10 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2025-01-09 | Needham | Maintain | Buy | Buy |
| 2024-11-12 | Needham | Maintain | Buy | Buy |
| 2024-10-31 | Needham | Maintain | Buy | Buy |
| 2024-10-31 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2024-10-31 | Oppenheimer | Maintain | Outperform | Outperform |
| 2024-04-09 | Needham | Maintain | Buy | Buy |
| 2024-03-05 | Oppenheimer | Maintain | Outperform | Outperform |
| 2024-03-05 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2024-03-05 | Needham | Maintain | Buy | Buy |
| 2024-03-05 | Craig-Hallum | Maintain | Buy | Buy |
| 2024-03-05 | Piper Sandler | Maintain | Overweight | Overweight |
| 2023-12-20 | Needham | Maintain | Buy | Buy |
| 2023-11-09 | Needham | Maintain | Buy | Buy |
| 2023-10-04 | Needham | Maintain | Buy | Buy |
| 2023-09-25 | Needham | Maintain | Buy | Buy |
| 2023-08-10 | Needham | Maintain | Buy | Buy |
| 2023-08-10 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2023-08-10 | Piper Sandler | Maintain | Overweight | Overweight |
| 2023-07-05 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2023-06-30 | Needham | Maintain | Buy | Buy |
| 2023-06-30 | Oppenheimer | Maintain | Outperform | Market Outperform |
| 2023-06-12 | Oppenheimer | Maintain | Outperform | Outperform |
| 2023-05-30 | Needham | Maintain | Buy | Buy |
| 2023-05-02 | Needham | Maintain | Buy | Buy |
| 2023-05-02 | LifeSci Capital | Maintain | Outperform | Outperform |
| 2023-05-02 | Oppenheimer | Maintain | Outperform | Outperform |
| 2023-05-02 | Ladenburg Thalmann | Maintain | Buy | Buy |
| 2023-05-02 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2023-04-28 | Needham | Maintain | Buy | Buy |
| 2023-04-17 | Needham | Maintain | Buy | Buy |
| 2023-04-03 | Oppenheimer | Maintain | Outperform | Outperform |
| 2023-04-03 | Needham | Maintain | Buy | Buy |
| 2023-03-23 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2023-02-27 | Oppenheimer | Maintain | Outperform | Outperform |
| 2023-02-24 | Needham | Maintain | Buy | Buy |
| 2023-02-07 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2023-02-07 | Needham | Maintain | Buy | Buy |
| 2022-11-30 | Jefferies | Upgrade | Hold | Buy |
| 2022-11-21 | Needham | Maintain | Buy | Buy |
| 2022-08-11 | SVB Leerink | Maintain | Outperform | Outperform |
| 2022-08-10 | Needham | Maintain | Buy | Buy |
| 2022-08-10 | Jefferies | Downgrade | Buy | Hold |
| 2022-05-31 | Needham | Maintain | Buy | Buy |
| 2022-05-27 | SVB Leerink | Maintain | Outperform | Outperform |
| 2022-05-27 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2022-01-11 | Needham | Maintain | Buy | Buy |
| 2021-09-23 | Needham | Maintain | Buy | Buy |
| 2021-03-10 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2020-07-21 | SVB Leerink | Maintain | Outperform | Outperform |
| 2020-06-30 | HC Wainwright & Co. | Maintain | Buy | Buy |
| 2020-05-04 | Piper Sandler | Maintain | Overweight | Overweight |
| 2020-04-03 | Jefferies | Maintain | Buy | Buy |
| 2020-03-12 | Stifel | Maintain | Buy | Buy |
| 2020-02-26 | Piper Sandler | Maintain | Overweight | Overweight |
| 2020-01-30 | Craig-Hallum | Maintain | Buy | Buy |
| 2019-09-24 | Laidlaw & Co. | Maintain | Buy | Buy |
| 2019-06-14 | Ladenburg Thalmann | Upgrade | Neutral | Buy |
| 2019-02-08 | Ladenburg Thalmann | Downgrade | Buy | Neutral |
| 2018-11-06 | Laidlaw & Co. | Downgrade | Buy | Hold |